Abstract
Background: In 1996, the number of persons newly infected with hepatitis C virus (HCV) in the US was estimated to be 36 000. As a chronic disease that primarily affects younger persons, hepatitis C has the potential to influence employment considerably.
Objective: To estimate employment effects associated with hepatitis C morbidity.
Design: An economic model of labour supply, which used the outcome measure workforce participation (yes/no), was applied.
Study participants: The study samples (by gender) were comprised of persons 18–65 years of age, with and without serological evidence of HCV infection, and with normal or elevated levels of alanine aminotransferase (ALT) who participated in the National Health and Nutrition Examination Survey III from 1988–1994. Results: After controlling for the potential confounding effects of demographic, social, and economic factors, positive HCV status/normal ALT level in males was associated with a 10.7% reduction in labour force participation (when compared with negative HCV status). Positive HCV status and elevated ALT levels was associated with a 17.5% reduction in employment. The results for females were not statistically significant.
Conclusions: Nationally, the employment response for HCV-positive status and elevated ALT levels translates into an excess non-employment of 48 000 males annually.
Similar content being viewed by others
References
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Moth Mortal Wkly Rep 1998; 47 (RR-19):1–39
Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000; 20: 17–35
Tailor S. Hepatitis C: a review [online]. Available from URL: http://www.pharmacyconnects.com/content/phpractice/2000/10-00/ce-l0.pdf [Accessed 2003 Apr16]
Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556–62
Wong JB, McQuillan GM, McHutchison JG, et al. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90: 1562–9
Summary of notifiable diseases, United States, 1998. MMWR Moth Mortal Wkly Rep 1999; 47 (53): 1–93
Dusheiko GM, Roberts JA. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal. Hepatology 1995; 22: 1863–73
Shiell A, Law MG. The cost of hepatitis C and the cost-effectiveness of its prevention. Health Policy 2001; 58 (2): 121–31
Leigh JP, Bowlus CL, Leistikow BN, et al. Costs of hepatitis C. Arch Intern Med 2001; 161: 2231–7
Bowen W, Finegan T. The economics of labor force participation. Princeton (NJ): Princeton University Press, 1969
Heckman J. Shadow prices, market wages, and labor supply. Econometrica 1974; 42 (4): 679–94
Bound J, Schoenbaum M, Waidmann T. Race and education differences in disability status and labor force attachment in the health and retirement survey. J Hum Resour 1995; 30 Suppl.: S227–67
Welch F. Wages and participation. J Labor Econ 1997; 15 (1 Pt 2): S77-S103
Kidd MP, Solane, PJ, et al. Disability and the labour market: an analysis of British males. J Health Econ 2000; 19 (6): 961–81
Goldberger AS. Econometric theory. New York: Wiley, 1964
Maddala GS. Limited-dependent and qualitative variables in econometrics. Cambridge: Cambridge University Press, 1983
Greene WH. Econometric analysis. 4th ed. Upper Saddle River (NJ): Prentice Hall, 2000
Gopal DV, Rosen HR. Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis. Postgrad Med 2000; 107: 100–2,105–9,113–4
Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284: 450–6
Rones PL, Ilg RE, Gardner JM. Trends in hours of work since the mid-1970s. Mon Labor Rev 1997; 120 (4): 3–14
Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556–62
Acknowledgements
We acknowledge the help and advice of Mitchell Halperin, Nadine MacLean, Gerald Minuk, Julia Uhanova, and Don Sin in the preparation of this manuscript. This paper is based on a project that was partly funded by Health Canada. The authors have provided no information on conflicts of interest directly relevant to the content of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jacobs, P., Ng, Y.C., Stafinski, T. et al. Labour Force Participation Among Individuals with Hepatitis C in the US. Pharmacoeconomics 21, 565–572 (2003). https://doi.org/10.2165/00019053-200321080-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-200321080-00003